MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems

Go back to MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems
Mannkind Corporation (NASDAQ: MNKD) Delayed: 3.66 -0.09 (2.4%)
Previous Close $3.75    52 Week High $2.51 
Open $3.75    52 Week Low $0.41 
Day High $3.81    P/E N/A 
Day Low $3.64    EPS $-0.64 
Volume 3,843,656       

Mannkind Corporation (NASDAQ: MNKD) Delayed: 3.66 -0.09 (2.4%)
Previous Close $3.75    52 Week High $2.51 
Open $3.75    52 Week Low $0.41 
Day High $3.81    P/E N/A 
Day Low $3.64    EPS $-0.64 
Volume 3,843,656